A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

Ítems similars

• A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
  per: Bleehen, N. M., et al.
  Publicat: (1993)
• Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.
  per: McIllmurray, M B, et al.
  Publicat: (1989)
• A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).
  per: Cerny, T., et al.
  Publicat: (1989)
• Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party.
  per: Bleehen, N. M., et al.
  Publicat: (1994)
• Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide
  per: Lu, Eric, et al.
  Publicat: (2019)